The later stages of infection by the Lyme disease pathogen, Borrelia burgdorferi, are characterized by the persistence of the organism in individuals possessing a strong anti-Borrelia immune response. This suggests that the organism is sequestered in a tissue protected from the immune system of the host or there is a reservoir of the organism residing within the cells of the host. In this report, the ability of B. burgdorfieri to gain entrance into human umbilical vein endothelial cells was explored as a model for invasion. Incubation of B. burgdorferi with human umbilical vein endothelial cells at ratios ranging from 200:1 to 5,000:1 resulted in the intracellular localization of 10 to 25% of B. burgdorfieri in 24 h. The intracellular location of the spirochetes was demonstrated by the incorporation of radiolabeled B. burgdorferi into a trypsin-resistant compartment and was confirmed by double-immunofluorescence staining which differentiated intracellular from extracellular organisms. Actin-containing microfflaments were required for the intracellular localization, indicating that the host cell participates in the internalization process. Activation of endothelial cells by agents known to increase the expression of several adhesion molecules had no effect on the interaction of B. burgdorfieri with the endothelial monolayer. This indicates that the endothelial receptor for B. burgdorfieri is constitutively expressed and that internalization is not dependent upon adhesion molecules whose expression is induced by inflammatory mediators. The demonstration of B. burgdorfieri within endothelial cells suggests that intracellular localization may be a potential mechanism by which the organism escapes from the immune response of the host and may contribute to persistence of the organism during the later stages of Lyme disease.
Lyme disease is caused by the tick-borne spirochete Borrelia burgdorferi (8, 19) . Infection by this organism causes multiple and varied symptoms which have been categorized into three stages (17, 27, 29) . The first stage involves the initial symptoms of the disease including erythema chronicum migrans at the site of the tick bite and more generalized flulike symptoms. The second and third stages of disease occur weeks to months after the first stage and can involve several different organs including cardiac tissue, the central nervous system, and joints. In general, infected humans and animals experiencing symptoms of stage II and III disease have an active anti-Borrelia immune response including both humoral and cellular immunity. Antibiotic therapy resolves stage II and III symptoms in most individuals, indicating that these later stages of disease are due to persistence of the organism. The ability of the spirochete to maintain infection in the presence of a specific immune response suggests that the organism may hide from the defenses of the host in the later stages of infection. The neurological involvement seen in some individuals and the improved success in treatment of patients with stage II and III disease with ceftriaxone, an antibiotic which crosses the blood-brain barrier, implies that the central nervous system may serve as a protective niche (11) . Other investigators have shown that B. burgdorferi can transcytose an endothelial monolayer, providing a mechanism by which these spirochetes could invade a variety of tissues (10, 30) . It has also been speculated that B. burgdorferi resides within cells of certain tissues during or between stages of disease, which could provide a second mechanism contributing to persistence by the organism (5, 26, 27) . * Corresponding author.
In this study we have addressed the possibility of B. burgdorferi localization within mammalian cells by determining if the spirochete could be demonstrated within human endothelial cells. Endothelial cells were chosen because spirochetes can penetrate endothelial monolayers and adhere to endothelial cells in vitro (10, 30, 31) and because damage to the endothelium has been observed in animals and patients infected with B. burgdorferi (12, 28) . Spirochete internalization by endothelial cells was demonstrated by the uptake of radiolabeled bacteria into a trypsin-resistant endothelial cell compartment. This was verified by visualization of the bacterium within the endothelial cell.
MATERIALS AND METHODS
Bacteria. Low-passage frozen stocks of the JD-1 strain of B. burgdorferi, provided by Sam Telford and Jose Ribeiro of the Harvard School of Public Health, were maintained at -70°C (23) . Frozen stocks were seeded in 16 Fig. 1 are from a typical experiment and demonstrate that both cell association and internalization continue to increase until 48 h, when both are maximal. In the experiment shown in Fig. 1 , 14% of the added spirochetes were adherent at 48 h and 11% were intracellular by this time. After a 24-h incubation period, 50 to 75% of spirochetes associated with HUVECs had reached a trypsin-resistant, intracellular location.
An experiment was performed to establish that spirochetes incubated in tissue culture medium were not clumping together and forming large complexes that would pellet under the conditions used to separate spirochetes from HUVECs. In this experiment, spirochetes were incubated for 24 h in wells containing endothelial growth medium but
on September 21, 2017 by guest http://iai.asm.org/ Downloaded from no HUVECs, centrifuged, and washed alone or mixed with HUVECs prior to centrifugation and washes. Of the spirochete counts, 3% was found in the pellet fraction when spun by themselves and 4% was found when the spirochetes were spun with HUVECs. In the experimental samples ( Fig. 1 to  5 ), the nonassociated spirochetes were removed first and counted as the supernatant fraction. Of the remaining cellassociated spirochetes, only 4% could be placed in the trypsin-resistant fraction because of trapping of spirochetes by the larger HUVEC cells or pelleting of spirochetes during the low-speed centrifugation. This is between 0.5 and 2% of the total spirochete counts added to the wells in the samples in Fig. 1 to 5 .
Effect of agents that alter endothelial cell function on internalization of B. burgdorferi. Further experiments were performed to characterize the invasion of HUVECs by spirochetes. Tumor necrosis factor (TNF) is known to enhance the binding of leukocytes to endothelial cells by its ability to rapidly increase endothelial expression of intercellular adhesion molecule 1 (24) and to induce synthesis and expression of endothelial cellular adhesion molecule 1 (6) and vascular cell adhesion molecule 1 (21) with a time optimum of 2 to 4 h. Since leukocyte binding to intercellular adhesion molecule 1 and endothelial adhesion molecule 1 on endothelial cells is followed by penetration of the endothelium, it is possible that spirochetes might follow a similar mechanism involving the same endothelial cell receptors. HUVECs were incubated with 100 U of TNF (Genentec) per ml or with media alone for 3 h at 37°C. Radiolabeled B. burgdorferi were then added to the HUVEC monolayers, and the monolayers were incubated for 30 min, 4 h, and 24 h to determine if increased expression of either of these receptors could enhance the endothelial cell binding and/or internalization of B. burgdorferi. In a parallel experiment performed with the same batch of HUVECs and TNF, the percentage of neutrophils bound by endothelial cells increased from 14 to 79% with TNF treatment, indicating that receptors for neutrophil adhesion had been induced. At early time points, TNF had no effect on the binding or internalization by HUVECs of B. burgdorferi, while at 24 h the internalization was reduced by about one third (Fig. 2) . The effect at 24 h is probably not the result of reduced expression of receptors but rather the result of destabilizing effects of TNF on cytoskeletal structures, as has been reported for bovine aortic endothelial cells (7) . This is consistent with findings presented in Fig. 3 (discussed below) in which disruption of the cytoskeleton prevented internalization of the spirochetes. The experiment presented in Fig. 2 provides strong evidence that none of the TNF-inducible adhesion molecules on endothelial cells serve as receptors for B. burgdorferi binding or internalization.
Stimulation of endothelial cells with histamine or with phorbol esters induces the rapid expression of the neutrophil adhesion molecule GMP-140 from preformed intracellular pools (16) . Incubation of endothelial cells with 60 ng of phorbol myristate acetate (Sigma) per ml for 30 min in Hanks balanced salt solution containing 0.5% albumin, conditions which stimulate endothelial cell binding of neutrophils, had no effect on the binding or internalization of B. burgdorferi (data not shown), suggesting that GMP-140 is not a receptor for this organism. (14, 32) .
The ability of trypsin to completely remove cell-associated bacteria from the cytochalasin D-treated endothelial cells (Fig. 3 , bottom line) demonstrates that this protocol successfully removes extracellular bacteria from endothelial cells and validates its usefulness in quantification of intracellular organisms. These findings are further supported by the fluorescent micrographs in Fig. 6E and F and in Table 1 , in which all spirochetes were extracellular in slides prepared from cytochalasin D-treated endothelial cells. Cytochalasin D appears to have no effect on the viability of the spirochetes, as the addition of 1 ,ug of cytochalasin D per ml to bacterial cultures for 24 h had no effect on the percentage of spirochetes that were motile (>95%).
Inhibition of internalization by rabbit anti-B. burgdorferi antiserum. The specificity of the interaction between B. burgdorferi and HUVECs was analyzed by testing for the ability of rabbit polyclonal antibody to B. burgdorferi to block binding and internalization. The addition of rabbit anti-B. burgdorferi antiserum reduced binding to 67% of the control, incubated with normal rabbit serum, and reduced internalization to 34% of the control at the 4-h time point (Fig. 4) . At the 24-h time point, no difference was detected between antibody-treated samples and controls in the experiment shown in Fig. 4 (31) .
Cell specificity of internalization. The specificity of uptake was examined by analysis of different host cells. Two dose-response experiments are shown in Fig. 5 in which the binding and internalization by HUVECs and HeLa cells of increasing numbers of B. burgdorferi were measured. Greater that 60% of those spirochetes associated with HUVECs were intracellular for each dose of spirochetes in Fig.  5A . This is in contrast to the binding to HeLa cells (Fig. SB) Strain specificity of bacterial uptake. A derivative of B. burgdorferi Sh-2-82, which has been passaged 300 times in the laboratory and shown to have lost the ability to infect white-footed mice, was tested for the ability to achieve an intracellular localization (26) . After a 24-h incubation period with HUVECs, 23% ± 0.2% of labeled spirochetes were associated with endothelial cells and 15% ± 0.1% of the organisms were intracellular. Therefore, the ability to achieve an intracellular localization is a property shared by both virulent and avirulent strains of B. burgdorferi. This is in further agreement with the endocytic nature of the internalization process.
Fluorescent-antibody staining of intracellular spirochetes. Double-staining techniques were used in which spirocheteinfected endothelial cells were stained before and after permeabilization with methanol (25) . Apparently intact spirochetes staining with both FITC-and rhodamine-conjugated goat anti-rabbit IgG were observed (Fig. 6A to D) , as were spirochetes staining only with rhodamine-conjugated second antibody (Fig. 6B and D, arrows) . Brightly stained intracellular debris was occasionally observed and was presumed to represent fragments of intracellular spirochetes. Neither intact spirochetes nor brightly staining speckles were identified in HUVECs not exposed to spirochetes (data not shown), confirming that the intracellular speckles were due to specific staining of spirochetal antigens rather than trapping of conjugated antibody by the HUVECs. Many spirochetes were found adhering to cytochalasin D-treated HUVECs; however, they always stained with both antibodies ( Fig. 6E and F) . This is consistent with the finding that all radiolabeled spirochetes adherent to cytochalasin D-treated endothelial cells could be released by trypsin. The data from a representative experiment are presented in tabular form in Table 1 . The fluorescent antibody studies permitted a much lower ratio of spirochetes to endothelial cells (approximately 30:1) than did the experiments assessing uptake of radiolabeled bacteria. This difference and differences in the integrity of the monlayer obtained with endothelial cells plated on glass coverslips rather on plastic are probably responsible for the lower ratio of spirochetes to endothelial cells detected in the stained samples relative to the results with uptake of radiolabeled spirochetes. The results of the fluo- rescent antibody staining ( Fig. 6 and Table 1 ) provide confirmation of the intracellular localization of B. burgdorferi within normal endothelial cells and the requirement for host microfilaments for this localization.
DISCUSSION
The achievement of an intracellular location within mammalian cells is a potent virulence factor for many bacterial species, including many which grow well in the extracellular environment. These include Yersinia spp., Salmonella spp., Shigella spp., invasive Escherichia coli, and L. monocytogenes (15) . Invasion by many of these organisms is associated with intracellular multiplication and cell-to-cell spreading. This may also result in invasion of other tissues (Salmonella spp. and L. monocytogenes) (14, 32) or may enhance survival in the localized site of infection (Shigella spp.) (9) . Other organisms appear to invade without replicating (Yersinia and Bordetella spp.) within the invaded cell and may use invasion as a mechanism of passing from one tissue to another (13) (14) (15) . The ability to invade cells provides the bacterium with a mechanism by which to escape destruction by the innate and specific aspects of the immune response of the host. An intracellular location may also provide protection from antibiotics because the concentration of many antibiotics within cells will be less than that in the extracellular milieu (15, 25) .
Because of the virulence potential of host cell invasion, we wanted to know if B. burgdorferi could reside within a mammalian cell. We wished to demonstrate this as a property distinct from the ability to transcytose an endothelial cell monolayer. Our results demonstrate that B. burgdorferi can achieve an intracellular localization in vitro and suggests that intracellular localization may occur in vivo. The ability to localize within tissue cells may allow the spirochete, which has a very slow division time (10 to 12 h under optimal conditions), a real opportunity to avoid killing by antibiotics, antibody-plus-complement-mediated lysis, or antibody-mediated phagocytosis, and allow survival of low levels of organisms for prolonged periods of time. One characteristic of the internalization process is a requirement for intact host cell microfilaments. This is consistent with the requirements for invasion by several other pathogenic bacteria and suggests that the host cell is actively participating in the invasion process (15) . Others have referred to this type of event as "parasite directed endocytosis," reflecting the participation of both the microbe and the host cell in the internalization process (20) . The tissue normally serving as a reservoir in vivo is not known, but the contrast in efficiency between the HeLa cell line and HUVECs suggests that some cell specificity will exist.
In the experiments presented in Fig. 1 to 5, the low specific activity of the metabolically labeled bacteria required a relatively high ratio of spirochetes to endothelial cells to measure internalization. The validity of these findings was confirmed by immunofluorescent analysis (Fig. 6 and ' Total number of spirochetes that stained after endothelial cell permeabilization with rabbit anti-B. burgdorferi antiserum and rhodamine-conjugated goat anti-rabbit IgG (detects both intracellular and extracellular bacteria). patient with dilated cardiomyopathy and the apparent localization of at least one spirochete within a myocardial cell (12, 28) .
There are two reports documenting another important interaction between B. burgdorferi and human endothelial cells, i.e., the ability to transcytose monolayers of endothelial cells (10, 30) . These findings are important as they provide a mechanism by which the spirochete can escape from the blood and move into a variety of tissues in the infected animal. In one report, it was suggested that B. burgdorferi interacts with fibronectin in the subendothelial matrix (30) ; however, the bacteria used in that study were labeled with [3H]thymidine, which others have shown not to be incorporated into B. burgdorferi (22) . In that study it is possible that much of the [3H]thymidine was associated with the surface of the bacterial cell instead of metabolically incorporated into bacterial DNA; therefore, it is difficult to interpret those antibody inhibition studies (30) .
We were not able to identify the cellular receptor for B. burgdorferi involved in endothelial cell uptake of this organism. Our results suggest that the expression of the endothelial cell receptor was not induced by incubation with the spirochetes because the slow kinetics did not reveal a lag time for binding or internalization ( Fig. 1 to 3 ). Additionally, two agents which induce inflammatory signals, TNF and phorbol myristate acetate, had no effect on binding or internalization, indicating that inflammatory stimulus was not required for expression of receptor or endocytic activity by the endothelial cells. In our studies, binding and internalization were seen with one noninfectious strain of B. burgdorferi, suggesting this is not the only determinant of infectivity. It will be interesting to compare the intracellular survival of infectious and noninfectious strains of B. burgdorferi.
The experiments described in this paper provide a model by which to study the role of intracellular survival in persistence of the spirochete during infection of the host. By studying this interaction in vitro, it should be possible to determine how long spirochetes can persist within endothelial cells and whether viable spirochetes can be recovered from endothelial cells. This model should allow characterization of the spirochete and endothelial cell molecules involved in infection. Further analysis of this interaction may provide information on the type of intracellular compartment in which the spirochetes reside and whether intact spirochetes and degraded spirochetes are associated with different types of cellular vacuoles. Information from these studies may also provide insight into the involvement of endothelial cell localization in the pathological aspects of Lyme disease.
